CHANDRA WILLIAMS: Open Payments
NPI 1497294102 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 85 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $1,504
Food & beverage: $1,504
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $241 |
| Lundbeck LLC | 9 | $157 |
| ABBVIE INC. | 13 | $152 |
| Corium, LLC | 9 | $121 |
| Tris Pharma Inc | 6 | $117 |
| Vanda Pharmaceuticals Inc. | 6 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Alkermes, Inc. | 4 | $94 |
| Supernus Pharmaceuticals, Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Azstarys, Dyanavel XR, FANAPT, ARISTADA, Qelbree.
Industry payments across GA — which companies pay providers there.
